Alzheimer's Disease
Research and Statistics
Alzheimer's disease is a tragic affliction that can cause a loved one to be unable to remember even the most basic of emotional connections. It can be a tough problem for any family to face, and in this article, we'll discuss some of the basic facts about Alzheimer's in order to give you a more complete understanding of the disease.
Alzheimer's disease is actually a form of dementia, a mental disorder that can cause a person to be able to lose the ability to perform the normal activities in their daily life. Alzheimer's is the most commonly occurring form of dementia, and as many as 4.5 million Americans alone suffer from the disease. At the current time, we don't have any type of cure for the disease, only preventative measures to help to stave off the disease's rate of damage. The disease most commonly occurs in those that are of age sixty or older, and the risk of contracting it increases as a person ages. As a matter of fact, those aged 85 and older face approximately a fifty percent risk of having the disease. That's not to say that the disease is simply caused by aging; scientists are unsure as to why some people become afflicted with the disease while others don't.
[Read More]
More Articles About Alzheimer's Disease
The Basics of Alzheimer's Disease
Alzheimer's disease is a tragic affliction that can cause a loved one to be unable to remember even the most basic of emotional connections. It can be a tough problem for any family to face, and in this article, we'll discuss some of the basic facts about...
African-Americans at an increased Alzheimer's risk
Alzheimer's disease often strikes those old in age and leaves them unable to perform the most basic of human functions. There are many factors that can contribute to Alzheimer's disease, and some groups are more at risk for...
Alzheimer's disease statistics
If you've ever known someone who was afflicted with Alzheimer's disease, you know exactly how devastating the disease can be. It's a terrible problem that can cause a person to lose the abilities to do...
Communicating with someone with Alzheimer's disease
Alzheimer's disease can be a very confusing condition to cope with. Individuals with the disease lose much of their communicative ability and their emotions may run rampant due to the fact that they no longer understand things as easily as...
Coping with Alzheimer's patients
When a person that you love comes down with Alzheimer's disease, it is a life-changing experience. It can be truly heartbreaking to see the person that you love beginning to lose their memories, and as the disease wears on, it becomes more and more troublesome to...
Diagnosing Alzheimer's disease
Alzheimer's disease is a devastating condition that can be very difficult to detect. The only true way that we have of diagnosing the condition is to perform an autopsy and note the presence of amyloid plaque in the brain
Medical advancements in the fight against Alzheimer's
One in three people in the United States of America know someone who has been afflicted with Alzheimer's disease. These people are the ones who can explain exactly how devastating the disease can be to not only...
Risk factors for Alzheimer's disease
One of the most common forms of dementia is a disease named Alzheimer's disease. Commonly occurring in those of an old age, the disease attacks the mind of the individual viciously, causing them to lose...
The history of Alzheimer's disease
Alzheimer's disease is a terrible problem that has been affecting those old in age for centuries. Most of the knowledge that we have about the affliction, we've learned within the past one hundred years.
The stages of Alzheimer's disease
Alzheimer's disease is a degenerative mental disorder that can leave a person confused and frustrated when it comes to simple activities like identifying a family member. The disease can be devastating for both the person afflicted with...
Alzheimer's Disease on the Web
Pfizer and Medivation: Dimebon co-development agreement (Pharmaceutical Business Review)
Pfizer and Medivation have signed a global co-development deal for Dimebon, a potential drug for Alzheimers disease treatment. Pfizer is already a major player in this market with its leading therapy Aricept. Datamonitor expects Dimebon to achieve sales revenue of $1.8 billion in the seven major markets by 2017, protecting Pfizer from significant revenue loss following Aricepts patent expiry. |
Stateline Area Health Notes (Beloit Daily News)
IMMUNIZATION CLINIC 4:30 - 6:30 p.m. Sept. 10 at the Rock County Health Department South Office, 61 Eclipse Center, Beloit; 8:30 - 10:30 a.m. every Monday, Wednesday and Friday by appointment only at the Rock County Health Department, 61 Eclipse Center, Beloit. Information, call (608)364-2010. |
My Pharmiweb.com (PharmiWeb)
AnaSpec Peptides Used in Latest Alzheimers Research Findings by VU University Medical Centre and Lund University AnaSpec Inc. Posted on:29 Aug 08 At the 2008 International Conference for Alzheimer’s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, “Aβ1-42 binding and uptake by primary human astrocytes in vitro: Effects of ... |
Alzheimer’s sufferer found (Vail Daily)
VAIL — A Vail man who has Alzheimer's disease was found unhurt Monday almost 24 hours after he disappeared from his home. Jeffrey Treneer Nicholls, 67, was found lying in bushes near a trail that extends from the end of Bald Mountain Road in East Vail, said Kris Friel, a town spokeswoman. |
|